These observations suggest that the activation of THBS1-AS1–mediated TGF-β signaling in CFs but not macrophages contribute to the cardiac fibrosis and suggest that targeting this signaling in CFs is effective for the treatment. Here, THBS1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.